Evidence method
Level · gp.fundamentals.debt_to_revenue
153.31% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
INDV · Mar 31, 2026
Indivior Pharmaceuticals, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-26-028850General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
6.31% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-2.84% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
19.17% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
47.95% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
87.38% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
43.22% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
2.84% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History7 statesHistory building
Period transition
What moved in the state?
- Previous
- 25.75%
- Current
- 153.31%
- Delta
- 127.57%
- Previous
- 5.33%
- Current
- 6.31%
- Delta
- 0.98%
- Previous
- -2.18%
- Current
- -2.84%
- Delta
- -0.66%
- Previous
- 4.29%
- Current
- 19.17%
- Delta
- 14.88%
- Previous
- 12.35%
- Current
- 47.95%
- Delta
- 35.60%
- Previous
- 80.23%
- Current
- 87.38%
- Delta
- 7.16%
- Previous
- 21.15%
- Current
- 43.22%
- Delta
- 22.07%
- Previous
- 2.10%
- Current
- 2.84%
- Delta
- 0.74%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Has State · Indivior Pharmaceuticals, Inc. →Transitioned To · INDV Fundamental State →Transitioned To · INDV BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · INDV CAPEX_INTENSITY_INCREASED →Transitioned To · INDV CASH_GENERATION_DECREASED →Transitioned To · INDV GROWTH_INCREASED →Transitioned To · INDV INVENTORY_PRESSURE_INCREASED →Transitioned To · INDV MARGIN_INCREASED →Transitioned To · INDV PROFITABILITY_INCREASED →Transitioned To · INDV SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.